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Introduction
Desmogleins (Dsgs) and desmocollins (Dscs) are transmem-
brane glycoproteins that anchor adjacent epithelial cells to one 
another in desmosomes via their five extracellular domains 
(EC1–5;  Green  and  Simpson,  2007;  Garrod  and  Chidgey, 
2008). The cytoplasmic domains of these desmosomal cad-
herins integrate the keratin-based cytoskeleton at stable sites 
of cell–cell contact by interacting with armadillo family mem-
bers, including plakoglobin (PG) and the plakophilins, which, 
in turn, associate with the intermediate filament-binding pro-
tein  desmoplakin.  The  resulting  supracellular  scaffolding 
gives tensile strength to tissues such as the heart and epider-
mis, which is required for effectively resisting the forces of 
mechanical stress.
The epidermis is a continually renewing stratified epithe-
lium that forms the outer protective layer of the skin. During the 
epidermal life cycle, superficial cells lost through desquamation 
are replenished with a fresh population of keratinocytes entering 
the terminal differentiation program from the proliferating basal 
compartment.  Desmosomal  cadherin  expression  profiles  are   
orchestrated with biochemical changes in growth factor signaling, 
cytoskeleton and cytoskeletal-associated proteins, and compo-
nents required for establishing the epidermal barrier (Green and 
Simpson, 2007). Of the four Dsg and three Dsc subtypes, Dsg2/
Dsc2 and Dsg3/Dsc3 are found in the basal layer. Conversely, 
Dsc1 is restricted to the postmitotic, upper cell layers, and Dsg4 
is present only in the most terminally differentiated viable cell 
layers. Dsg1 exhibits a distinct expression pattern from other 
desmosomal cadherins in that it is first expressed at the interface 
between basal and suprabasal cells. Alterations in the normal 
expression pattern of desmosomal cadherins in mice disrupts 
epidermal structure and function, supporting the notion that 
these adhesion molecules also serve as key morphoregulators 
  D
sg1 (desmoglein 1) is a member of the cadherin 
family of Ca
2+-dependent cell adhesion molecules 
that is first expressed in the epidermis as keratino-
cytes transit out of the basal layer and becomes concen-
trated  in  the  uppermost  cell  layers  of  this  stratified 
epithelium. In this study, we show that Dsg1 is not only 
required for maintaining epidermal tissue integrity in the 
superficial layers but also supports keratinocyte differen-
tiation and suprabasal morphogenesis. Dsg1 lacking 
N-terminal ectodomain residues required for adhesion   
remained capable of promoting keratinocyte differentiation. 
Moreover, this capability did not depend on cytodomain 
interactions with the armadillo protein plakoglobin or   
coexpression of its companion suprabasal cadherin, Dsc1 
(desmocollin 1). Instead, Dsg1 was required for suppres-
sion of epidermal growth factor receptor–Erk1/2 (extra-
cellular signal-regulated kinase 1/2) signaling, thereby 
facilitating keratinocyte progression through a terminal 
differentiation program. In addition to serving as a rigid 
anchor between adjacent cells, this study implicates desmo-
somal cadherins as key components of a signaling axis 
governing epithelial morphogenesis.
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experiments reveal that desmosomal cadherin functions tran-
scend adhesion by networking with cell surface receptors that 
control epithelial morphogenesis.
Results
Dsg1 is required for suprabasal 
morphogenesis of organotypic human 
epidermal cultures
The analysis of Dsg1 function in vivo is complicated by the 
presence of two additional and highly homologous genes 
(dsg1- and dsg1-) with overlapping expression patterns to 
dsg1- in the epidermis of mice (Brennan et al., 2004). To de-
termine the normal requirements for Dsg1 in stratified epithe-
lial morphogenesis, we turned to an organotypic raft model 
of  human epidermis to study the single human DSG1 gene 
purely  in  keratinocytes  in  a  more  morphologically  relevant 
context than submerged cultures.
Dsg1 was present in rafts and exhibited a restricted expres-
sion pattern in differentiating keratinocytes (Fig. 1, A and B). As 
expected, Dsg1 was primarily found in the suprabasal layers that 
formed after 9 d at an air–liquid interface, whereas Dsg3 was 
immunolocalized between adjacent basal keratinocytes and was 
more abundant in the lower epidermal cell layers (Fig. 1 A). To 
test whether Dsg1 adhesive functions were conserved in these 
three-dimensional cultures, keratinocytes were matured on rafts 
for 9 d and then incubated for 24 h in the presence or absence of 
recombinant Staphylococcus aureus exfoliative toxin A (ETA; 
acute ETA treatment), a Ser protease which specifically cleaves 
after a Glu residue (381) located between EC3 and EC4 of Dsg1 
but  does  not  target  other  cadherins  (Amagai  et  al.,  2000; 
Hanakawa et al., 2004; Nagasaka et al., 2004). Similar to the 
phenotypic outcome in humans with ETA-induced bullous 
impetigo or Staphylococcal scalded skin syndrome, efficient 
removal of EC1–3 from Dsg1 in mature rafts resulted in promi-
nent areas of dissociation between adjacent keratinocytes in the 
uppermost cell layers (Fig. 1, C and D). These regions corre-
sponded to cell layers in which Dsg1 expression was most abun-
dant and which further lacked Dsg3. Importantly, ETA had no 
effect on the protein levels or integrity of Dsg3 or the related 
Dsg2 and Dsg4, with the latter two found in lower abundance in 
raft cultures (Fig. 1, B and D). These observations helped vali-
date the raft model for Dsg1 functional analysis.
Dsg1 was commonly detected at the interface between basal 
and suprabasal keratinocytes (Fig. 1 A), leading us to posit that 
this desmosomal cadherin might play an early instructive role as 
epidermal cells commit to a differentiation program. To address 
this possibility, we silenced Dsg1 expression in raft cultures using 
retroviruses  engineered  to  express  microRNA  (miRNA)-like 
sequences specific for this desmosomal cadherin (miR DG1) or 
lamin A/C (miR Lmn) as a control. Unlike lamin A/C–silenced 
rafts, there was a marked disorganization in the suprabasal lay-
ers that formed in Dsg1-deficient cultures (Fig. 2, A–C). In com-
parison with controls, we noted widened intercellular spaces 
(Fig. S3), irregular cell shapes in the intermediate layers (Fig. 2,   
D and E), and an immature granular layer suggestive of impaired 
differentiation (Fig. 2 A). Expression of a companion suprabasal 
(Koch et al., 1998; Chidgey et al., 2001; Elias et al., 2001; Merritt 
et al., 2002; Kljuic et al., 2003; Hardman et al., 2005; Brennan 
et al., 2007; Chen et al., 2008). For example, the lack of Dsc1 or 
Dsg4 in the suprabasal layers impairs adhesion, proliferation, 
and differentiation of keratinocytes in interfollicular epidermis 
or hair follicles (Chidgey et al., 2001; Kljuic et al., 2003). The 
adhesive function of desmosomal cadherins is thought to be 
critical for this process, as the transgenic expression of an 
ectodomain-deleted Dsg3 interferes with desmosome formation 
and epidermal differentiation (Allen et al., 1996). A causal link 
between  desmosomal  adhesion  and  epithelial  morphogenesis 
was further shown using inhibitory peptides that target amino 
acid residues present within EC1 of the adhesive cadherin ecto-
domain, which disrupt the positioning of luminal and myo-
epithelial cells in vitro (Runswick et al., 2001).
Desmosomal cadherins are part of a larger gene family 
that includes epithelial cadherin (E-cadherin), which is a critical 
orchestrator of intercellular junctional complexes and signaling 
pathways in epithelial tissues (Lien et al., 2006). Therefore, it 
has been suggested that, in addition to serving as adhesion 
receptors, desmosomal cadherins might also contribute to epi-
dermal morphogenesis by coordinating intracellular signaling 
responses  (Green  and  Simpson,  2007;  Garrod  and  Chidgey, 
2008). In support of this possibility, the forced expression of 
Dsc3 into the suprabasal layers not only led to epidermal prolif-
eration and differentiation defects but also increased -catenin 
signaling (Hardman et al., 2005). Similarly, introducing the 
basally restricted Dsg2 into the suprabasal layers enhanced epi-
dermal proliferation and survival in a manner that relied, at least 
in part, on EGF receptor (EGFR) and nuclear factor B signal-
ing (Brennan et al., 2007). However, these studies did not directly 
test whether the alterations in signaling were related to the adhe-
sive function of desmosomal cadherins.
To define the adhesive and signaling contributions of des-
mosomal  cadherins  in  epithelial  tissue  morphogenesis,  we 
focused on the role of Dsg1 in epidermal development because 
it is essential for adhesion in the uppermost cell layers and can 
be found at the interface between cells in the basal and supra-
basal layers in vivo, where keratinocytes commit to a terminal 
differentiation program (Green and Simpson, 2007; Garrod 
and Chidgey, 2008). Providing further rationale for focusing on 
this particular desmosomal cadherin, the Grhl1 (grainyhead-
like 1) transcription factor directly regulates DSG1 gene expres-
sion, and knockout of Grhl1 in mice leads to epidermal adhesive 
and differentiation defects (Wilanowski et al., 2008). Using a 
three-dimensional  raft  model  of  human  epidermis  combined 
with  gain-  and  loss-of-function  approaches,  we  demonstrate 
that Dsg1 regulates an early program of epidermal differentia-
tion and morphogenesis that leads to an up-regulation of Dsc1 
along with other suprabasal layer proteins. Interestingly, Dsg1 
can promote keratinocyte differentiation in a manner that does   
not rely on its (a) suprabasal partner, Dsc1, (b) N-terminal ecto-
domain residues required for Dsg1-dependent adhesion, or (c)   
association with PG. Instead, our results demonstrate that Dsg1 
is required for dampening EGFR–Erk1/2 signaling in the supra-
basal layers, thus allowing for the progression of keratinocytes 
toward a more differentiated phenotype. Collectively, these   1245 DESMOGLEIN 1 REGULATES EPIDERMAL MORPHOGENESIS • Getsios et al.
periphery (Fig. 2 D). Dsg1-deficient keratinocytes were, on 
average, almost twice as large and more variable in size com-
pared with those present in the suprabasal layers of miR Lmn 
rafts (Fig. 2 E). These data support the idea that an increase in 
Dsg1 expression is required for the normal adhesion and mor-
phological  transformation  of  keratinocytes  transitioning  into 
the suprabasal epidermis.
cadherin, Dsc1, was markedly reduced; in contrast, the levels 
of  classical  and  other  desmosomal  cadherins  present  in  the 
lower layers were only marginally affected by the loss of Dsg1 
and remained prominent at areas of cell–cell contact (Fig. S1).
The gross disturbances in cellular organization led us to 
more closely evaluate suprabasal keratinocyte morphology by 
imaging the cortical actin cytoskeleton, which outlines the cell 
Figure 1.  Differentiation-dependent Dsg1 maintains adhesion in the superficial layers of epidermal raft cultures. (A) IHC analysis of Dsg1 and Dsg3 in 
frozen sections prepared from 9-d-old rafts. Dsg1 was concentrated in the suprabasal layers (insets with dashed lines), whereas Dsg3 was prominent in 
the basal layer (insets with continuous lines). (B) Real-time PCR analysis of Dsg1–4 mRNA levels from keratinocytes maintained as submerged cultures 
(Sub day 0) or on rafts for 3, 6, or 9 d. The Dsg mRNA levels were normalized to cyclophilin 1 levels interpolated from a standard curve, and the mean 
of three independent experiments (±SEM) is represented in the graph. Dsg1 mRNA levels were tightly coordinated with raft maturation, whereas Dsg3 
remained relatively constant. Maximal Dsg2 (0.0468 ± 0.0318) and Dsg4 (0.000874 ± 0.000101) mRNA transcript levels were detected in submerged 
and day 9 raft cultures, respectively. (C) H&E-stained sections of 9-d-old rafts incubated with or without 5 µg/ml recombinant ETA (acute ETA) for 24 h. 
Boxed insets show areas of cell–cell dissociation in the uppermost layers of ETA-treated rafts, whereas control cultures remained intact. (D) Western blot 
analysis of these raft cultures using a cytoplasmic domain (CYTO) antibody for Dsg1 demonstrated that the N-terminal portion (aa 1–381) of the adhesive 
ectodomain (ECTO) of the full-length protein (Dsg1 FL) was efficiently cleaved in the presence of ETA, resulting in a membrane-associated cytoplasmic 
fragment (Dsg1 CL; aa 382–1,049) that was retained in whole cell lysates. Dsg2–4 were not cleaved by ETA. GAPDH, glyceraldehyde-3-phosphate   
dehydrogenase; TM, transmembrane domain. Bars: (A and C) 50 µm; (insets) 20 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1246
with the histological analysis, rafts lacking Dsg1 exhibited a 
marked reduction in both early (Dsc1 and keratin 10 [K10]) 
and late markers (loricrin and processed filaggrin) of epider-
mal differentiation (Fig. 3, B and C). In addition, prolifera-
tion, as assessed by Ki67 staining and BrdU incorporation 
(Fig. S2), and the expression of proteins more prominent in 
the basal layer such as K14 remained unchanged in Dsg1-
deficient cultures.
Dsg1 regulates epidermal differentiation 
independent of ectodomain residues 
required for adhesion
To determine whether the aberrant morphology of stratifying 
keratinocytes in Dsg1-deficient cultures was accompanied by 
alterations in the differentiation program, we investigated the 
expression  of  several  well-characterized  structural  proteins 
that are induced upon keratinocyte differentiation. Consistent 
Figure 2.  Dsg1 deficiency impairs morphogenesis of epidermal raft cultures. (A) H&E-stained sections of 6-d-old rafts expressing miR Lmn or miR DG1. 
Dsg1-deficient rafts exhibited abnormal suprabasal morphology (insets with continuous lines) and a poorly differentiated appearance (insets with dashed 
lines) compared with controls. (B) IHC analysis of Dsg1 in miR Lmn or miR DG1 rafts revealed a profound loss of Dsg1 at 6 d. The keratinocyte–collagen 
interface is highlighted by the dotted line. (C) Western blot analysis of Dsg1, Dsg3, lamin A/C (Lmn A/C), and GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) from these raft cultures indicated that Dsg1 or lamin A/C levels were reduced by 90%. (D) An actin antibody was used to highlight   
the cellular cortex in Dsg1-deficient cultures and generate surface area measurements of individual suprabasal cells using indirect immunofluorescence   
staining. Although control cultures exhibited compact, uniformly shaped suprabasal cells, cultures lacking Dsg1 possessed suprabasal cells that displayed 
a highly irregular array of individual cell sizes. Boxed insets highlight suprabasal cell morphology between miR Lmn and miR DG1 rafts. (E) The surface 
area from individual suprabasal cells (n > 150) from miR Lmn or miR DG1 rafts was measured using MetaMorph software, and individual data points from 
a representative experiment are shown in the scatter plot. Bars: (A, B, and D) 50 µm; (insets) 20 µm.1247 DESMOGLEIN 1 REGULATES EPIDERMAL MORPHOGENESIS • Getsios et al.
induced to differentiate and throughout their development (chronic 
ETA treatment). Consistent with previous studies in which trun-
cated desmosomal cadherins were introduced into epithelial cells 
(Allen et al., 1996; Serpente et al., 2000), EM analysis revealed 
adhesive defects in these ETA-treated rafts with a reduction in 
suprabasal  desmosome  density  similar  to  that  observed  upon 
To determine whether impaired morphogenesis and differ-
entiation in knockdown rafts were solely caused by the loss of 
Dsg1-mediated  adhesion,  we  chronically  removed  N-terminal 
ectodomain residues required for Dsg1-dependent adhesion 
(Getsios et al., 2004) by incubating rafts in wild-type (WT) or 
protease-deficient (mut) ETA as soon as these cultures were 
Figure 3.  N-terminal ectodomain residues of Dsg1 required for adhesion are not essential for epidermal raft development. (A) H&E analysis of raft cultures 
treated with WT ETA (ETA WT) or a protease-dead mutant (ETA mut) and maintained at an air–liquid interface for an additional 6 d. Chronic Dsg1 EC1–3 
cleavage did not grossly alter suprabasal morphogenesis. (B) Western blot analysis revealed a reduction in Dsc1, K10, filaggrin, and loricrin in raft cul-
tures deficient in Dsg1 (miR DG1) compared with miR Lmn controls. In contrast, there were no differences in the levels of these suprabasal proteins in rafts 
treated with ETA WT or mut. Levels of Dsg3 and the basal marker K14 were equivalent in all conditions. Black lines indicate that intervening lanes have 
been spliced out. CL, cleaved; FL, full length; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (C) IHC staining confirmed that both K10 and Dsc1 
(Figs. S1 and S4) were reduced in Dsg1-silenced cultures (miR DG1), whereas control (miR Lmn) and ETA-treated (ETA WT) cultures robustly expressed these 
suprabasal markers. Also, note that ETA-treated cultures retained a cleaved fragment (aa 382–1,049) of Dsg1 at intercellular borders, as revealed by stain-
ing with an antibody against the cytoplasmic domain of Dsg1 (Dsg1 cyto), whereas the extracellular epitope (aa 1–381) was effectively removed by ETA 
(inset). The dotted lines indicate the boundary between keratinocytes and the collagen matrix. (D) The mean surface area (±SEM) of individual suprabasal 
cells from ETA-treated or Dsg1 knockdown rafts was determined using actin immunostaining to outline the cell cortex. Although control and ETA-treated 
cultures exhibited suprabasal cells of similar size, cultures lacking Dsg1 possessed suprabasal cells that were nearly twice as large. Bars, 50 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1248
Dsg1 silencing (Fig. S3). In stark contrast to miR DG1 rafts, 
chronic removal of the Dsg1 EC1–3 did not appreciably alter the 
cellular organization or size of suprabasal cells, which differenti-
ated normally and remained grossly intact despite 6 d of constant 
exposure to ETA (Fig. 3, A–D). As in the case of acute ETA treat-
ment (Fig. 1 D), the other desmosomal cadherins remained intact 
in raft cultures chronically exposed to ETA (Fig. S4). However, 
similar to immature embryonic and neonatal human skin (Wu 
et al., 2000), Dsg3 was more broadly distributed throughout all 
viable layers in the earlier 6-d-old raft cultures treated with 
ETA WT or ETA mut (Fig. S4) or silenced for Dsg1 expression 
(Fig. S1), perhaps contributing to the overall maintenance of 
tissue integrity (Figs. 2 A and 3 A) compared with acute ETA 
treatment at day 9, when the uppermost cell layers lack Dsg3 
(Fig. 1 C). Collectively, these observations demonstrated that, 
in spite of comparable alterations in cell–cell adhesion in both 
Dsg1 cleavage and Dsg1 knockdown conditions, differentia-
tion was impaired only in cells lacking Dsg1 altogether, indi-
cating that the residual cleaved Dsg1 (aa 382–1,049) supported 
normal morphogenesis.
To establish that impaired progression through the differ-
entiation program was a direct result of Dsg1 deficiency, a full-
length  Dsg1  cDNA  with  silent  point  mutations  rendering  it 
resistant to miR DG1 was simultaneously introduced along with 
retroviral miRNA into keratinocytes that were differentiated in 
rafts (Fig. 4 A) as well as submerged cultures (Fig. 4 B). The 
reconstitution of Dsg1 was capable of increasing the levels of 
Dsc1, K10, and loricrin in raft cultures (Fig. 4 A). Importantly, 
ETA-mediated cleavage of the EC1–3 domains of this Dsg1 res-
cue construct still allowed for restoration of these structural 
markers of keratinocyte differentiation (Fig. 4 B). These data 
provided direct evidence that Dsg1 can promote keratinocyte 
differentiation even when the N-terminal residues required for 
adhesion have been removed.
Dsg1 promotes keratinocyte differentiation 
independent of Dsc1 levels, PG binding, or 
ectodomain residues required for adhesion
Consistent with previous work in human epidermis (Arnemann 
et al., 1993; Donetti et al., 2005; Bazzi et al., 2006), Dsc1 and 
Dsg4 exhibit a more restricted expression pattern than Dsg1 in 
the suprabasal layers of rafts (Fig. 5 A and not depicted). Dsg4-
deficient mice exhibit major hair follicle defects, but the inter-
follicular epidermis, where this desmosomal cadherin is limited 
to the most differentiated viable cell layers, is relatively normal 
(Kljuic et al., 2003). Moreover, the low levels of Dsg4 protein 
Figure 4.  Reconstitution of Dsg1 restores epidermal differentiation despite 
ectodomain cleavage. (A) Western blot analysis of keratinocytes cotrans-
duced with miR Lmn or miR DG1 (DG1 KD) and either EGFP (DG1 Resc ) 
or silencing refractory WT or PG-binding mutant (AAA) Dsg1 constructs 
and then grown as raft cultures. Although Dsg1 was more efficiently 
silenced at day 3 (top), modest silencing was still evident at day 6 (bottom) 
with concomitant reduction of differentiation markers. Cotransduction with 
either miR-resistant Dsg1 WT or Dsg1 AAA was sufficient to increase Dsg1 
levels and restore Dsc1/K10/loricrin levels to that of controls. (B) Similar 
rescue experiments were performed in submerged culture in which Dsg1 
silencing was more efficient. Silencing of Dsg1 (DG1 KD) resulted in a 
decrease in Dsc1/K10 levels, and this deficiency was rescued by the 
silencing-resistant Dsg1 (DG1 Resc +; third lane) but not a susceptible WT 
Dsg1 construct (DG1 Resc ; second lane). Moreover, chronic treatment   
with ETA efficiently cleaved the N-terminal portion of the adhesive ecto-
domain of the Dsg1 rescue construct but did not affect its ability to rescue dif-
ferentiation in Dsg1-silenced keratinocytes (fifth lane). Black lines indicate 
that intervening lanes have been spliced out. CL, cleaved; FL, full length; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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Figure 5.  Dsg1 promotes keratinocyte differentiation in a manner that does not rely on its regulation of Dsc1 expression. (A) Dual-label IHC staining 
revealed that Dsg1 (red) is expressed in lower cellular layers of day 6 rafts compared with Dsc1 (green). A merged overlay image containing DAPI (blue) 
as a nuclear stain is mounted to the right. The dotted lines indicate the boundary between keratinocytes and the collagen matrix. (B) Real-time PCR analysis 
showed that Dsc1 mRNA levels are reduced in Dsg1 knockdown rafts. The mRNA levels of Dsg1, Dsc1, and a gene target of EGFR, EphA2, were normal-
ized to 18-S ribosomal RNA using the comparative CT method. The data are representative of four independent experiments and are shown as fold change 
from miR Lmn controls. (C) Ectopic Dsg1-Flag in keratinocytes maintained in low (0.2 mM) Ca
2+ to limit differentiation results in a time-dependent increase 
in Dsc1 expression compared with EGFP-transduced controls. Protein lysates from 0 to 4 d after retroviral transduction were analyzed using an antibody 
specific for Dsg1 (ectopic + endogenous), Dsc1, or tubulin as a loading control. (D) Dsg1-Flag was ectopically expressed in keratinocytes and additionally 
transfected with a pool of Dsc1 siRNA or control oligonucleotides (75 nM total) for 48 h in low Ca
2+. Confluent cultures were switched into high (1.8 mM) 
Ca
2+ to initiate differentiation and harvested after 24 h. Ectopic Dsg1 was capable of increasing the levels of differentiation-associated proteins, whereas 
the levels of p-EGFR were reduced. Dsc1 knockdown (KD) did not interfere with the Dsg1-dependent changes in K10, loricrin, or p-EGFR. Ratios of p-EGFR 
to total EGFR are indicated above the blots. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Bar, 50 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1250
in developing raft cultures did not change in response to Dsg1 
silencing or cleavage (unpublished data). In addition, Dsg4 
was limited to a single superficial cell layer in 6-d-old raft cul-
tures, and this distribution did not change in ETA-treated or 
knockdown rafts (unpublished data). However, Dsg1 silencing 
led to a coordinate reduction in Dsc1, including at the mRNA 
level (Fig. 5 B), and ectopic Dsg1 expression was capable of 
increasing Dsc1 levels (Fig. 5 C; Getsios et al., 2004). As Dsc1 
plays an important role in epidermal integrity and differentia-
tion in mice (Chidgey et al., 2001), it was possible that Dsg1 
initiated a cascade of events leading to the induction of Dsc1, 
which, in turn, was responsible for differentiation. We tested 
this  possibility  by  silencing  Dsc1  expression  and  asking 
whether this desmosomal cadherin was required for Dsg1-
mediated differentiation. Ectopic expression of Dsg1 in sub-
merged keratinocyte cultures was sufficient to increase markers 
of terminal differentiation, including Dsc1 (Fig. 5 D). Impor-
tantly, Dsg1 remained capable of promoting keratinocyte dif-
ferentiation even when Dsc1 induction was blocked by siRNA 
treatment (Fig. 5 D).
Previous  experiments  showed  that  the  misexpression  of 
Dsc3 in the suprabasal epidermis increased -catenin stability 
and signaling (Hardman et al., 2005). However, Dsg1-deficient 
rafts exhibited a variable decrease in Dsc3 levels but no changes 
in -catenin distribution or activation (Fig. S1). Moreover, ecto-
pic expression of Dsg1 was capable of inducing differentiation 
without altering levels of Dsc3 or -catenin (unpublished data). 
The desmosomal counterpart to -catenin, PG, is a major binding 
partner for the Dsg1 cytoplasmic domain and has been shown to 
play a key role in nuclear signaling and keratinocyte differentia-
tion (Chitaev et al., 1998; Teuliere et al., 2004; Williamson et al., 
2006). Thus, this armadillo family member served as a logical 
candidate for mediating Dsg1-dependent differentiation. There-
fore, we mutated three hydrophobic residues important for PG 
binding within the Dsg1 cytoplasmic domain to assess its contri-
bution to Dsg1-mediated differentiation (Dsg1AAA; Fig. 6 A; 
Chitaev et al., 1998). Although Dsg1AAA still concentrated at 
areas of cell–cell contact (Fig. 6 B), its association with PG was 
severely limited as compared with the WT protein (Fig. S5). 
Despite this profound deficiency in PG binding, Dsg1AAA and 
WT Dsg1 were equally capable of restoring the levels of Dsc1, 
K10, and loricrin in Dsg1-deficient rafts (Fig. 4 A). Moreover, ec-
topic expression of either of these Dsg1 constructs increased dif-
ferentiation markers (Fig. 6 C). These findings demonstrate that 
introduction of Dsg1 into keratinocytes is sufficient to accelerate 
a program of terminal differentiation and emphasize that recruit-
ment of additional PG by this ectopic desmosomal cadherin is not 
a critical step in this cascade of differentiation-promoting events.
Because ETA-cleaved Dsg1 (Fig. 3 C) and the PG-binding 
mutant (Fig. 6 B) were both localized to intercellular junctions, we 
next asked whether the Dsg1 cytoplasmic domain itself was able 
to promote keratinocyte differentiation. A truncated mutant of this 
desmosomal cadherin lacking an extracellular and transmembrane 
domain (N-Dsg1; Fig. 6 A) failed to localize at cell–cell junc-
tions (Fig. 6 B) and exhibited increased solubility (Fig. S5 B) but 
retained the ability to bind PG, although not as efficiently as the 
full-length protein (Fig. S5 A). In contrast to WT Dsg1, which was 
capable of increasing Dsc1, K10, and loricrin expression even 
upon cleavage by ETA (Fig. 4 B), the levels of these differentiation 
markers were unchanged compared with controls upon ectopic 
N-Dsg1 expression (Fig. 6 C). These findings suggested that the 
Dsg1 cytoplasmic tail may need to be anchored at the cell surface 
to trigger keratinocyte differentiation.
Dsg1 is required for the suppression  
of EGFR–Erk1/2 signaling during  
keratinocyte differentiation
EGFR is concentrated and active in the basal layer where it main-
tains proliferating keratinocytes in an undifferentiated state (Stoll 
et al., 2001; Lacouture, 2006). Although this receptor Tyr kinase 
continues to be expressed in the suprabasal epidermis, which is 
coordinated with the induction of Dsg1, it is no longer active 
upon stratification, allowing these cells to adopt a more differen-
tiated phenotype. The inability of a soluble Dsg1 tail to regulate 
keratinocyte differentiation suggests that localization is impor-
tant. This observation led us to speculate that Dsg1 might be 
required to suppress EGFR signaling in the suprabasal layers and 
allow for normal progression through the epidermal differentia-
tion program. In support of this possibility, phosphorylated EGFR 
was largely restricted to the basal layer of control rafts, but sus-
tained activation and expansion of this activated receptor into the 
suprabasal layers were found after Dsg1 knockdown (Fig. 7, 
A and B). The reciprocal relationship between EGFR activity and 
Dsg1 was examined in more detail by ectopic expression of this 
desmosomal  cadherin  in  submerged  keratinocytes. These  two 
transmembrane proteins did not overlap extensively in the cyto-
plasm but were colocalized within discrete regions of cell–cell 
contact (Fig. 7 C, zoom). Moreover, Dsg1 was capable of reduc-
ing the levels of activated EGFR in a manner that did not require 
Dsc1 (Fig. 5 D). Finally, the ectopic expression of Dsg1 but not 
the soluble Dsg1 tail was capable of recruiting EGFR and the re-
lated erbB2 receptor into a more insoluble pool (Fig. 7 D).
To determine whether the suppression of EGFR and erbB2 
contributed to Dsg1-dependent differentiation, we inhibited these 
receptor Tyr kinases in keratinocytes lacking Dsg1. We reasoned 
that Dsg1-deficient cultures would be rescued by global inhibi-
tion of EGFR–erbB2 if their sustained activation was responsible 
for impaired differentiation. For this purpose, we incubated miR 
DG1–transduced keratinocytes with a dual specificity inhibitor 
(PKI166) for EGFR and erbB2 (Fig. 7 B; Traxler et al., 2001). In 
submerged cultures transduced with miR DG1, the inhibition of 
EGFR–erbB2 was capable of restoring the levels of early differ-
entiation markers without inducing Dsg1 expression. However, 
chronic inactivation of the EGFR–erbB2 pathway by PKI166 
failed to support raft culture maturation, which is consistent with 
its vital role in epidermal development in vivo (Miettinen et al., 
1995; Murillas et al., 1995).
To identify downstream effectors of EGFR affected by Dsg1 
deficiency, we examined the expression and activation status of 
the MAPK Erk1/2. Consistent with increased EGFR activity, the 
phosphorylation of Erk1/2 was elevated upon Dsg1 knockdown 
and was suppressed by PKI166 treatment (Fig. 7 B). In contrast to 
Dsg1-deficient cultures, the Ras–Raf–Mek (MAPK/extracellular 
signal-regulated kinase [Erk] kinase)–Erk1/2 pathway was   1251 DESMOGLEIN 1 REGULATES EPIDERMAL MORPHOGENESIS • Getsios et al.
Figure 6.  Dsg1 promotes differentiation in the absence of robust PG binding. (A) To test which domains of Dsg1 would be sufficient to drive differentiation, 
we generated three Flag-tagged Dsg1 cDNA constructs: WT Dsg1 (Dsg1WT), a triple point mutant harboring three Ala substitutions (Dsg1AAA) within the 
predicted binding region for PG, or a truncation mutant lacking the ectodomain (ECTO) and transmembrane (TM) region (N-Dsg1). CYTO, cytoplasmic 
domain. (B) The subcellular localization of Dsg1WT, Dsg1AAA, or N-Dsg1 was determined in keratinocytes immunostained using a rabbit polyclonal 
antibody directed against Flag and a chicken polyclonal antibody against PG after exposing cells to high Ca
2+ for 4 h to induce junction assembly. Both 
Dsg1WT and Dsg1AAA were efficiently recruited to areas of cell–cell contact; however, N-Dsg1 was diffusely distributed throughout the cytoplasm. PG 
staining highlighted the intercellular borders; its localization at junctions was largely unaffected by any of the Dsg1 constructs. (C) Western blot analysis 
of keratinocytes transduced with these Dsg1 constructs and induced to differentiate for 2 d as submerged cultures. Although Dsg1WT and Dsg1AAA were 
sufficient to increase Dsc1/K10/loricrin, N-Dsg1 did not affect these markers of differentiation compared with EGFP-transduced (Dsg1) control cultures. 
FL, full length; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Bar, 20 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1252
Figure 7.  Dsg1 is required for the suppression of EGFR–Erk1/2 signaling during epidermal differentiation. (A) IHC analysis of Dsg1 (left) and EGFR phos-
phorylated at Y1068 (p-EGFR; right) revealed a basally restricted p-EGFR staining pattern largely absent from Dsg1-positive suprabasal layers in control 
(miR Lmn) cultures, whereas Dsg1-deficient cultures (miR DG1) demonstrated a gross disorganization of p-EGFR, which was present throughout the basal 
and suprabasal layers. The dotted lines indicate the boundary between keratinocytes and the collagen matrix. (B) Western blot analysis of keratinocytes 
transduced with miR Lmn or miR DG1 and induced to undergo differentiation for 2 d as submerged cultures in the presence or absence of 10 µM of the 
EGFR–erbB2 inhibitor PKI166 (PKI). A significant increase in p-EGFR, p-erbB2, and p-Erk1/2 levels was detectable in keratinocytes upon Dsg1 silencing 
(Dsg1 KD) along with decreased K10/Dsc1. Blocking EGFR signaling using PKI166 suppressed p-EGFR, p-erbB2, and p-Erk levels in addition to restoring 
the capacity of Dsg1-deficient keratinocytes to differentiate. Ratios of p-EGFR to total EGFR or p-Erk1/2 to total Erk1/2 are indicated above the blots. 1253 DESMOGLEIN 1 REGULATES EPIDERMAL MORPHOGENESIS • Getsios et al.
Simpson, 2007; Garrod and Chidgey, 2008). However, because 
Dsg1 is first expressed as keratinocytes transit into the supra-
basal layers, we considered an additional function for Dsg1 in 
regulating the differentiated state of epidermal cells. To define 
the role of Dsg1, we used gain- and loss-of-function approaches 
in a simplified in vitro model of human epidermis. These ex-
periments revealed that Dsg1 is not only required for maintain-
ing epidermal tissue integrity but also plays a key role in 
morphogenesis. Importantly, Dsg1 promotes epidermal differ-
entiation in a manner that involves proper down-regulation of 
EGFR–Erk1/2  signaling  but  does  not  rely  on  ectodomain 
residues required for adhesion, the ability to bind PG, or co-
ordinated Dsc1 expression. These experiments place Dsg1 in 
an early instructive pathway that directs the progression of 
keratinocytes through a terminal differentiation program.
Our data support a model in which Dsg1 acts as an   
important node in an epidermal adhesion and signaling network 
(Fig. 8 D). Keratinocytes held together by desmosomal cad-
herins in the basal layer are capable of responding to signals 
from EGFR to maintain steady-state proliferation in the epi-
dermis. We propose that induction of Dsg1 serves to facilitate 
progression into a terminally differentiated state, at least in 
part, by preventing the sustained activation of the EGFR–Erk1/2 
pathway in the suprabasal layers. However, basal layer des-
mosomal cadherins such as Dsg2 and Dsc3 might potentiate 
these growth promoting signals. In support of this possibility, 
transgenic misexpression of Dsg2 or Dsc3 in the suprabasal 
layers of mice results in elevated Erk1/2 signaling and im-
paired  differentiation,  respectively  (Hardman  et  al.,  2005; 
Brennan et al., 2007). Thus, basal and suprabasal desmosomal 
cadherins with opposing signaling potentials could serve to 
balance keratinocyte proliferation and differentiation to main-
tain epidermal tissue homeostasis.
Dsg4 exhibits a highly differentiation-dependent expres-
sion pattern in the human epidermis, being expressed in the 
uppermost viable cell layers above Dsg1, Dsc1, and K1/10 (Bazzi 
et al., 2006). Accordingly, the expression of these suprabasal 
proteins is unchanged in Dsg4 mutant mice that instead exhibit 
defects in hair follicle differentiation (Kljuic et al., 2003). In 
the present study, Dsg4 levels and distribution also remained 
unchanged in 6-d-old raft cultures in response to Dsg1 silenc-
ing or cleavage. Thus, Dsg4 likely plays a temporally and 
functionally distinct role from Dsg1, which is active in earlier 
epidermal differentiation events. However, coordination of 
desmosomal cadherin expression and growth factor signaling 
may be in play during hair follicle differentiation, where loss 
of Dsg4 or EGFR leads to premature differentiation of these 
unaltered in ETA-treated raft cultures (Fig. 7 E). To determine 
whether the Erk1/2 pathway, which had previously been impli-
cated in keratinocyte differentiation (Gazel et al., 2008; Kolev 
et al., 2008), contributed to the defects upon Dsg1 knockdown, 
we used a pharmacological compound (U0126) with high speci-
ficity for the upstream kinase MEK1/2 (Davies et al., 2000). 
Similar to EGFR–erbB2 inhibition, the suppression of Erk1/2 
restored differentiation in submerged cultures (Fig. 8 C) but also 
allowed for rescue of suprabasal differentiation in Dsg1 knock-
down rafts (Fig. 8, A and B).
Multiple signaling pathways beyond Erk1/2 are activated 
downstream of EGFR, including other MAPKs, PI3 kinase/
AKT, and conventional PKCs. To determine their involvement 
in Dsg1-dependent differentiation, we inhibited these other 
kinases also implicated in keratinocyte differentiation (Denning 
et al., 1995; Calautti et al., 2005; Gazel et al., 2008). Although 
the activation of these downstream kinases were commonly 
elevated in Dsg1-deficient keratinocytes (shown for AKT; 
Fig. 8 C), the inhibition of these signaling pathways was not 
sufficient to restore differentiation as in the case of Erk1/2 
suppression (not depicted). These findings suggest that Erk1/2 
suppression is specifically required for Dsg1-mediated differenti-
ation, which is consistent with a recent study on EGFR-mediated 
effects on keratinocytes (Kolev et al., 2008). In particular, 
inhibition of p38 MAPK did not rescue differentiation or alter 
the Erk1/2 pathway other than the expected down-regulation 
of the common MAPK target c-Fos (Fig. 8 C). In contrast, 
U0126 restored differentiation and was shown to decrease the 
levels of activated Erk1/2 and a specific target of the EGFR–Erk 
pathway, EphA2 (Larsen et al., 2007), without changing the 
activation of other EGFR effectors such as AKT. Consistent 
with the idea that the Dsg1 effects were mediated through ele-
vated EGFR–Erk1/2 signaling, we found a marked increase 
in EphA2 mRNA (Fig. 5 B) and protein (Fig. 7 E) in Dsg1 
knockdown but not ETA rafts. Because U0126 treatment also 
increased levels of Dsc1, we again ascertained that differentia-
tion was rescued despite Dsc1 silencing (unpublished data). In 
summary, these findings place Dsg1 upstream in a signaling 
pathway leading to the suprabasal inhibition of EGFR–Erk1/2 
signaling, which permits proper epidermal differentiation and 
morphogenesis.
Discussion
The targeting of Dsg1 by autoimmune antibodies and bacterial 
toxins causes blistering in the uppermost cell layers of the epi-
dermis,  highlighting  its  importance  in  adhesion  (Green  and 
Tx, treatment. (C) Dual-label indirect immunofluorescence and Apotome optical sectioning of Dsg1-Flag and EGFR after 4 h in high Ca
2+ revealed areas of 
overlap in discrete regions of cell–cell contact (zoom) but not throughout the cell. The boxed area is magnified in the right panel. (D) Keratinocytes were 
transduced with EGFP, WT Dsg1-Flag (DG1-WT), or a soluble, truncated Dsg1 mutant (N-DG1) and switched into high Ca
2+ before being harvested in 
RIPA buffer. The insoluble pellet was resuspended in buffered SDS and run in parallel with equal protein amounts from the RIPA-soluble fraction. The ratio 
of insoluble/total erbB2, EGFR, E-cadherin (E-cad), and K14 is presented in the bar graph and is representative of three experiments. Full-length but not 
the truncated Dsg1 recruits EGFR–erbB2 into a more insoluble fraction where keratins are concentrated. Under these detergent conditions, the vast majority 
of E-cadherin remains in the soluble fraction. (E) Activation of EGFR-Ras-Raf-Erk signaling effectors as well as the EGFR–Erk1/2 gene target, EphA2, were 
elevated by Dsg1 knockdown but not chronic ETA treatment in rafts. Ratios of p-Erk to total Erk are indicated above the blots. GAPDH, glyceraldehyde-
3-phosphate dehydrogenase. Bars: (A) 50 µm; (C) 20 µm.
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In this study, we show that ETA-cleaved Dsg1 supports normal 
epidermal morphogenesis, demonstrating that this transmem-
brane  protein  can  orchestrate  a  key  signaling  pathway  in  a 
manner that does not depend on ectodomain residues required 
for adhesion. E-cadherin, which is present in all viable epider-
mal cell layers (Hirai et al., 1989) has also been found to   
inhibit  EGFR  signaling,  although  downstream  Erk1/2  phos-
phorylation was largely unaffected upon direct ligation of its 
adhesive ectodomain (Qian et al., 2004; Perrais et al., 2007). 
Moreover, classical cadherin depletion grossly disrupts epidermal 
keratinocytes with resultant hair defects (Hansen et al., 1997; 
Kljuic et al., 2003).
Directly interfering with desmosomal cadherin adhesion 
using small peptides that target EC1 of Dsg2 and Dsc2 dis-
rupted epithelial positioning in an organotypic model of mam-
mary alveolar morphogenesis (Runswick et al., 2001). The 
possibility that, in addition, desmosomal cadherins play supra-
adhesive roles in development is supported by the observation 
that Dsg2- and Dsc3-null mutant mouse embryos die before 
desmosome formation (Eshkind et al., 2002; Den et al., 2006). 
Figure 8.  Erk1/2 inhibition restores epidermal differentiation in Dsg1-deficient keratinocytes. (A) Western blot analysis of control or Dsg1 knockdown 
(KD) raft cultures incubated in the presence of vehicle control (DMSO) or 5 µM U0126. U0126 restored p-Erk1/2 to control levels and was able to 
increase Dsc1/K10/loricrin on the background of Dsg1 silencing. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (B) IHC analysis of K10 in 3-d-old 
control or Dsg1-deficient rafts treated with DMSO or U0126. Erk1/2 inhibition led to markedly improved suprabasal K10 expression. The dotted lines 
indicate the boundary between keratinocytes and the collagen matrix. (C) Treatment (Tx) of Dsg1-deficient keratinocytes with an inhibitor of Erk1/2 (5 µM 
U0126) or p38 MAPK (10 µM SB203580) signaling in submerged cultures induced to differentiate for an additional 2 d. Western blot analysis revealed 
a restoration of loricrin and K10/Dsc1 (not depicted) levels toward control keratinocytes upon suppression of p-Erk1/2 levels despite the lack of Dsg1. 
U0126 suppressed p-Erk1/2 and reduced downstream c-Fos and EphA2 expression but had no effect on p-AKT levels. Keratinocyte differentiation was not 
rescued using SB203580, which decreased c-Fos expression but not p-Erk1/2, p-AKT, or EphA2 levels. (A and C) Ratios of p-Erk to total Erk are indicated 
above the blots. (D) A model depicting the coordination of EGFR–Erk1/2 signaling and Dsg expression during epidermal differentiation. The expression 
of Dsg2 and Dsg3 is permissive for EGFR–Erk1/2 signaling in the basal layer, which suppresses terminal differentiation. In contrast, the induction of Dsg1 
in the suprabasal layers dampens EGFR–Erk1/2 activity, allowing for the progression into a more differentiated state and expression of Dsc1, K10, and 
loricrin. Our findings predict that shifting the balance toward Dsg1 would cause premature differentiation, whereas the absence of Dsg1 in the suprabasal 
epidermis is expected to limit differentiation via the sustained activity of EGFR–Erk1/2. Consistent with animal models in which Dsg2 has been transgeni-
cally overexpressed (Brennan et al., 2007), increasing this desmosomal cadherin in the suprabasal layers can compete with Dsg1 function and promote 
persistent EGFR–Erk1/2 signaling and impaired differentiation. Bar, 50 µm.1255 DESMOGLEIN 1 REGULATES EPIDERMAL MORPHOGENESIS • Getsios et al.
the underlying dermis and immune system. Although reduced 
adhesion may account for some of these skin defects, our data 
raise the possibility of the EGFR–Erk1/2 signaling pathway as 
a novel therapeutic target for restoring epidermal architecture in 
patients with hyperkeratotic skin disease.
In summary, we have uncovered a novel role for desmo-
somal cadherins in epithelial differentiation by limiting the sig-
naling potential of other cell surface receptors. In particular, 
Dsg1 is required for suppressing EGFR–Erk1/2 signaling to 
allow for normal epidermal differentiation and morphogenesis in 
a manner that does not rely on its adhesive capability but more 
likely on unique properties of the cytoplasmic tail or binding 
partners that are regulated by this extended region. Therefore, 
Dsg1 has multiple roles in the epidermis: instructing an early 
epidermal differentiation program upon stratification and main-
taining robust adhesion in the uppermost layers.
Materials and methods
Generation of cDNA and miRNA constructs
The full-length human Dsg1 cDNA with a C-terminal Flag epitope in pTRE 
(p812) and pLZRS-Linker (p1007) along with pLZRS-pBMN-EGFP (p990) 
have been previously described (Getsios et al., 2004). An miRNA-resistant 
Dsg1 construct was generated from p812 by site-directed mutagenesis 
(Agilent Technologies) to incorporate two silent point mutations within the 
miR DG1 target region. Dsg1 deficient in PG binding was generated by 
incorporating three Ala substitutions (Leu751Ala; Phe755Ala; Leu758Ala) 
within the predicted binding region for PG (Dsg1AAA; Chitaev et al., 1998). 
The Dsg1 cytodomain-only construct (N-Dsg1; aa 569–1,049) was gener-
ated by PCR amplification of a fragment of p812. All of these Flag-tagged 
Dsg1 cDNAs were subcloned into the BamHI site of pLZRS-Linker.
RNA interference of human lamin A/C (miR Lmn) or Dsg1 (miR 
DG1)  was  performed  using  miRNA  155–mimicking  sequences  cloned 
downstream of the 3 untranslated region of EGFP. The EGFP cDNA was 
excised from pEGFP-N1 (Clontech Laboratories, Inc.) using EcoRI and NotI 
and subcloned into pME18S-f1 (a gift from K. Fujiwara, University of   
Rochester, Rochester, NY). The 3 untranslated region (NotI–XbaI) was modified   
to contain two BstXI sites for insertion of oligonucleotide duplexes, and the 
resultant plasmid was termed pMIRAGE-G. Antisense and sense oligo-
nucleotide duplexes for miR Lmn or miR DG1 were annealed as previously 
described (Brummelkamp et al., 2002), phosphorylated using T4 poly-
nucleotide kinase, and ligated in tandem into the BstXI sites of pMIRAGE-G. 
The EGFP-miR EcoRI and XbaI fragments were then blunted with Klenow 
fragment and subcloned into the HindIII–XhoI site of pLZRS-Linker. Dsc1 
silencing was performed using a pool of three Stealth siRNA oligonucleo-
tides (25 nM each; Invitrogen) targeting this desmosomal cadherin or a 
GC-matched negative control, which were introduced into keratinocytes 
using the Dharmafectin1 transfection reagent (Thermo Fisher Scientific).
Constructs encoding WT and protease-dead (S195A) S. aureus ETA 
(Hanakawa et al., 2002) were provided by J. Stanley (University of Penn-
sylvania, Philadelphia, PA).
Cell culture and retroviral transduction
Epidermal keratinocytes were isolated from human foreskin as previously 
described (Halbert et al., 1992). The cells were propagated in medium 154 
supplemented with human keratinocyte growth supplement, 1,000× genta-
mycin/amphotericin B solution (Invitrogen), and 0.07 or 0.2 mM CaCl2.
Keratinocytes  were  transduced  with  retroviral  supernatants  pro-
duced from Phoenix cells (provided by G. Nolan, Stanford University, Stan-
ford, CA) as previously described (Getsios et al., 2004). For differentiation 
of submerged cultures, cells were grown to confluence and switched to 
E-medium containing 1.8 mM Ca
2+ for 1–6 d (Meyers and Laimins, 1994). 
For raft cultures, transduced cells were expanded and grown at an air– 
medium interface according to published protocols (Meyers and Laimins, 
1994). Organotypic cultures were grown for 3–10 d, at which time they 
were lysed for RNA/protein analysis, embedded in optimal cutting tem-
perature compound for frozen sections, fixed in 10% neutral-buffered 
formalin, and embedded in paraffin for histology or fixed in 2% para-
formaldehyde/2% glutaraldehyde in cacodylate buffer for EM analysis. 
integrity but does not result in MAPK-Erk1/2 activation or K10 
loss (Tinkle et al., 2004, 2008). Therefore, the necessity of Dsg1 
to suppress EGFR–Erk1/2 signaling and promote differentia-
tion in a manner that does not require its adhesive ectodomain 
appears to be distinct from E-cadherin and represents a novel 
mechanism by which the activity of this receptor Tyr kinase 
can be regulated upon stratification.
The Dsg1 tail itself was unable to promote keratinocyte 
differentiation, although the cytoplasmic domain likely contrib-
utes to epidermal morphogenesis when anchored at the plasma 
membrane. Importantly, Dsg1’s ability to recruit PG was not 
essential for triggering keratinocyte differentiation. This raises 
the possibility that the extended cytoplasmic tail of Dsg1, which 
harbors several additional regions outside of the catenin-binding 
site and not present in other cadherins, may recruit cytoplasmic 
proteins to the cell surface to regulate EGFR function. One such 
candidate could be the ERM (ezrin, radixin, moesin) family 
member, merlin, which has been shown to prevent EGFR sig-
naling by sequestration of this receptor Tyr kinase into a more 
insoluble pool (Curto et al., 2007; Cole et al., 2008) in a manner 
similar to ectopic Dsg1 (Fig. 7 D).
In the absence of Dsg1, the sustained activation of EGFR–
Erk1/2 in the suprabasal layers impaired differentiation without 
major changes in steady-state proliferation (Fig. S2). Because 
keratinocytes in different epidermal layers exhibit distinct 
responses to Ras-mediated Erk signaling (Bailleul et al., 1990; 
Brown et al., 1998), it is not too surprising that proliferation was 
unaltered by Dsg1 deficiency. However, our data support the 
notion that persistence of EGFR–Erk1/2 in the suprabasal lay-
ers prevents the induction of K10, which is not only a critical 
component of the intermediate filament network in differenti-
ated keratinocytes but also limits the size of these cells in the 
upper layers (Reichelt and Magin, 2002). This could help   
explain why suprabasal keratinocytes lacking Dsg1 are larger and 
more variable in size compared with their WT counterparts and 
may contribute to persistent Erk1/2 signaling (Reichelt et al., 
2004; Yano et al., 2004). Finally, Erk1/2 can activate CCAAT/
enhancer-binding  protein  family  members,  which  have  been 
shown to regulate Dsc promoter activity (Hu et al., 2001; Smith 
et al., 2004). This might account for the defects in Dsc1 expres-
sion beyond posttranslational stabilization of this Dsg1-binding 
partner in the suprabasal layers. In support of this possibility, 
Dsc1 mRNA levels are markedly reduced upon Dsg1 silencing 
(Fig. 5 B). The ability of Dsg1 to induce Dsc1 expression is 
likely an important step in constructing robust adhesion com-
plexes in the suprabasal epidermis because Dsg1-deficient rafts 
have desmosome defects (Fig. S3), but Dsc1 is not absolutely 
required for aspects of the Dsg1-mediated differentiation path-
way reported in this study (Fig. 5 D).
Interestingly, skin blisters are not common in individuals 
with Dsg1 haploinsufficiency, who instead exhibit thickening 
in specific regions of the epidermis, which undergo extensive 
mechanical stress (Rickman et al., 1999; Wan et al., 2004). 
Alterations  in  the  epithelial  thickness  were  not  apparent  in 
Dsg1-deficient rafts, which might reflect differences in how 
keratinocytes respond to the lack of Dsg1 in situ because of sig-
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retrieval was performed by heating to 95°C in 0.01 M of citrate buffer. 
Sections were blocked in 10% normal goat or horse serum (Jackson Immuno-
Research  Laboratories)  for  60  min  at  37°C,  incubated  in  primary   
antibody in 0.5% BSA overnight at 4°C, incubated in secondary antibody 
in 0.5% BSA for 60 min at 37°C, and mounted in polyvinyl alcohol. For 
frozen sections, optimal cutting temperature compound–embedded rafts 
were air dried, fixed in 4% paraformaldehyde, permeabilized in buffered 
0.2% Triton X-100, and immunostained as described in the previous sen-
tence. For immunocytochemistry of submerged cultures, cells were grown 
on glass coverslips, fixed in 3.7% formyl saline for 10 min at room temper-
ature, permeabilized in acetone at 20°C for 2 min, and then processed 
for immunofluorescence as previously described (Getsios et al., 2004). 
Images were obtained with a 40× NA 1.0 Plan-Fluotar or a 63× NA 1.32 
Plan-Apochromat objective on a microscope (DMR; Leica) using a charge-
coupled device camera (Orca 100 model C4742-95; Hamamatsu Photon-
ics) for fluorescence or a digital camera (DFC320; Leica) for color images 
and MetaMorph 6.1 software (MDS Analytical Technologies). For optical 
sectioning of tissue sections or colocalization experiments, images were 
acquired using a 20× NA 0.5 EC Plan-Neofluar or a 63× NA 1.4 Plan-
Apochromat objective, respectively, on an epifluorescence microscope sys-
tem (AxioVision Z1; Carl Zeiss, Inc.) fitted with an Apotome slide module 
and a digital camera (AxioCam MRm; Carl Zeiss, Inc.). For EM, raft cul-
tures were fixed in 2% paraformaldehyde/2% glutaraldehyde and pro-
cessed for conventional EM analysis as described previously (Green et al., 
1991). Samples were viewed and photographed on an electron micro-
scope (100CX; JEOL).
Raft cell size and proliferation analysis
Raft  sections  were  processed  for  immunohistochemistry  using  antiactin 
(C4; Thermo Fisher Scientific) and DAPI. The size of suprabasal cells was 
quantitated by tracing the cortical actin outline of each cell and measuring 
the enclosed area using MetaMorph 6.1 software. Greater than 150 cells 
were measured for each condition; individual and mean cell sizes (±SEM) 
were graphed. To assess Ki67 expression and BrdU incorporation, rafts were 
pulsed with 10 µM BrdU for 1 h and then fixed after chasing with fresh   
media for 24 h and processed for IHC analysis. BrdU- or Ki67-positive cells 
were divided by the total number of DAPI-stained nuclei from 10 random 
fields; >500 cells were counted for each condition, and the percentage 
was graphed ±SD.
Online supplemental material
Fig. S1 shows that the expression and distribution of desmosomal and 
classical  cadherins  beyond  Dsc1  remain  unchanged  in  Dsg1-silenced 
raft cultures. Fig. S2 shows that Ki67 expression and BrdU incorpora-
tion  are  unaltered  in  Dsg1-deficient  raft  cultures.  Fig.  S3  shows  adhe-
sion defects by ultrastructure of chronic ETA-treated or Dsg1 knockdown 
cultures  using  EM.  Fig.  S4  shows  that  the  expression  and  distribution 
of  desmosomal  and  classical  cadherins  remain  unchanged  in  chronic 
ETA-treated  raft  cultures.  Fig.  S5  shows  the  expression,  detergent  solu-
bility, and PG-binding capability of the Dsg1 cDNA constructs used in 
this study. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.200809044/DC1.
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et al., 2006); 27B2 (anti–Dsg1 cytodomain; Invitrogen); 6D8 and 18G8 
(anti-Dsg2 and -Dsg4, respectively; gift from J. Wahl III, University of 
Nebraska Medical Center, Omaha, NE); AK15 (anti-Dsg3; gift from   
M. Amagai, Keio University, Minato-ku, Tokyo, Japan); U100 and U114 
(anti-Dsc1a/b and -Dsc3a/b, respectively; RDI); 11E4 (anti-PG; gift from   
J. Wahl III); HECD1 (anti–E-cadherin; Takara); 8E7 (anti–activated -catenin/
ABC;  Millipore);  LH2  (anti-K10)  and  LL002  (anti-K14;  both  gifts  from   
E.B. Lane, University of Dundee, Dundee, Scotland, UK); AKH1 (antifilaggrin; 
gift from R. Presland, University of Washington, Seattle, WA); C4 (antiactin; 
Thermo Fisher Scientific); anti-EGFR (Thermo Fisher Scientific); anti–EGFR 
phospho-Y1068 (p-Y1068; Cell Signaling Technology); D7 (anti-EphA2; 
Millipore); E7 (-tubulin) and anti-BrdU (Developmental Studies Hybridoma 
Bank); and M2 (anti-Flag; Sigma-Aldrich).
Polyclonal antibodies used included 1407 (chicken anti-PG; Aves 
Laboratories);  c2206  (-catenin;  Sigma-Aldrich);  rabbit  antiloricrin  (gift 
from D. Roop and M. Koster, Baylor College of Medicine, Houston, TX; 
Covance);  rabbit  anti-GAPDH  (glyceraldehyde-3-phosphate  dehydroge-
nase; Abcam); 982 (human anti–Dsg1 extracellular domain pemphigus 
foliaceus sera) and 1905 (rabbit anti-Dsg3; both gifts from J. Stanley); rabbit 
anti-Ki67 (Dako); rabbit anti-Flag and anti-erbB2 (Cell Signaling Technol-
ogy); rabbit anti-EGFR, p-Ser473-AKT, p–c-Raf, and p-MEK1/2 (Cell Sig-
naling Technology); c-Fos and lamin A/C (Santa Cruz Biotechnology, Inc.); 
and rabbit anti-Erk1/2 and anti–p-Erk1/2 (Promega).
Secondary antibodies used for Western blotting included goat anti–
mouse, –rabbit, and –chicken peroxidase (Rockland; KPL). Secondary anti-
bodies used for immunoperoxidase-DAB (Sigma-Aldrich) staining included 
biotinylated horse anti–mouse and –rabbit (Jackson ImmunoResearch Labo-
ratories).  Secondary  antibodies  used  for  immunofluorescence  included 
goat anti–mouse, –rabbit, –chicken, and –human linked to fluorophores of 
488 nm and 568 nm (Alexa Fluor; Invitrogen). DAPI (Sigma-Aldrich) was 
used  for  nuclear  staining.  BrdU  was  purchased  from  Sigma-Aldrich.   
Recombinant S. aureus WT or protease-dead (S195A) ETA was produced 
and purified as previously described (Hanakawa et al., 2002).
Real-time PCR
Total RNA was extracted in Tri-Reagent solution (Molecular Research Cen-
ter, Inc.), DNase I (Invitrogen) treated, and reverse transcribed using the 
iScript cDNA synthesis kit (Bio-Rad Laboratories) according to the manu-
facturer’s instructions. Real-time PCR was performed on a sequence detec-
tor (SDS5700; Applied Biosystems) using the IQ SYBR green Supermix kit 
(Bio-Rad Laboratories) as directed by the manufacturer. Intron spanning 
primers were designed for human cyclophilin 1 and Dsg1–4 mRNA. For 
each experimental cDNA sample, the relative level of Dsg mRNA was 
interpolated from a standard curve for cyclophilin 1 that was generated from 
the analysis of serially diluted standards. Primer Bank (http://pga.mgh 
.harvard.edu/primerbank/) was used to select primers for the analysis of 
Dsg1, Dsc1, and EphA2 mRNA, which were normalized to 18-S ribo-
somal RNA using the comparative CT method (2-
( CT)) after amplification 
using the Power SYBR green Master Mix (Applied Biosystems), and are 
represented as fold changes from control miR Lmn rafts.
Protein expression, solubility, and immunoprecipitation analysis
Protein was extracted from monolayer or raft cultures using urea sample 
buffer for whole cell lysates or radioimmunoprecipitation assay (RIPA) buf-
fer containing 1% protease inhibitor cocktail (Sigma-Aldrich) and 1% phos-
phatase inhibitor cocktails II and IV (EMD) for phospho-specific antigens, 
immunoprecipitations, and detergent solubility experiments. Flag-tagged 
proteins were immunoprecipitated with anti-Flag M2-agarose (Sigma-
Aldrich) and analyzed by SDS-PAGE and immunoblotting as described pre-
viously (Chen et al., 2002). RIPA-soluble and -insoluble fractions as well as 
immunoprecipitated complexes were denatured in SDS buffer and sub-
jected to SDS-PAGE and Western blot analysis as previously described 
(Getsios et al., 2004). Relative band intensities for phosphorylated pro-
teins were normalized to total protein levels calculated using ImageJ soft-
ware (National Institutes of Health).
Histology, immunohistochemistry, immunocytochemistry, and EM analysis
Raft cultures were sectioned and processed for immunohistochemical (IHC) 
or hematoxylin and eosin (H&E) staining using conventional methods. Antigen 1257 DESMOGLEIN 1 REGULATES EPIDERMAL MORPHOGENESIS • Getsios et al.
Elias, P.M., N. Matsuyoshi, H. Wu, C. Lin, Z.H. Wang, B.E. Brown, and J.R. 
Stanley. 2001. Desmoglein isoform distribution affects stratum corneum 
structure and function. J. Cell Biol. 153:243–249. 
Eshkind, L., Q. Tian, A. Schmidt, W.W. Franke, R. Windoffer, and R.E. Leube. 
2002. Loss of desmoglein 2 suggests essential functions for early embry-
onic development and proliferation of embryonal stem cells. Eur. J. Cell 
Biol. 81:592–598. 
Garrod,  D.,  and  M.  Chidgey.  2008.  Desmosome  structure,  composition  and   
function. Biochim. Biophys. Acta. 1778:572–587. 
Gazel, A., R.I. Nijhawan, R. Walsh, and M. Blumenberg. 2008. Transcriptional 
profiling defines the roles of ERK and p38 kinases in epidermal keratino-
cytes. J. Cell. Physiol. 215:292–308. 
Getsios, S., E.V. Amargo, R.L. Dusek, K. Ishii, L. Sheu, L.M. Godsel, and K.J. 
Green. 2004. Coordinated expression of desmoglein 1 and desmocollin 1 
regulates intercellular adhesion. Differentiation. 72:419–433. 
Green,  K.J.,  and  C.L.  Simpson.  2007.  Desmosomes:  new  perspectives  on  a   
classic. J. Invest. Dermatol. 127:2499–2515. 
Green, K.J., T.S. Stappenbeck, S. Noguchi, R. Oyasu, and L.A. Nilles. 1991. 
Desmoplakin expression and distribution in cultured rat bladder epithelial 
cells of varying tumorigenic potential. Exp. Cell Res. 193:134–143. 
Halbert, C.L., C.W. Demers, and D.A. Galloway. 1992. The E6 and E7 genes of 
human papilloma virus type 6 have weak immortalizing activity in human 
epithelial cells. J. Virol. 66:2125–2134.
Hanakawa, Y., N.M. Schechter, C. Lin, L. Garza, H. Li, T. Yamaguchi, Y. Fudaba, 
K. Nishifuji, M. Sugai, M. Amagai, and J.R. Stanley. 2002. Molecular 
mechanisms of blister formation in bullous impetigo and staphylococcal 
scalded skin syndrome. J. Clin. Invest. 110:53–60.
Hanakawa, Y.,  N.M.  Schechter,  C.  Lin,  K.  Nishifuji,  M. Amagai,  and  J.R. 
Stanley. 2004. Enzymatic and molecular characteristics of the efficiency 
and specificity of exfoliative toxin cleavage of desmoglein 1. J. Biol. 
Chem. 279:5268–5277. 
Hansen,  L.A.,  N. Alexander,  M.E.  Hogan,  J.P.  Sundberg, A.  Dlugosz,  D.W. 
Threadgill, T. Magnuson, and S.H. Yuspa. 1997. Genetically null mice 
reveal a central role for epidermal growth factor receptor in the differ-
entiation of the hair follicle and normal hair development. Am. J. Pathol. 
150:1959–1975.
Hardman, M.J., K. Liu, A.A. Avilion, A. Merritt, K. Brennan, D.R. Garrod, and 
C. Byrne. 2005. Desmosomal cadherin misexpression alters beta-catenin 
stability and epidermal differentiation. Mol. Cell. Biol. 25:969–978. 
Hirai, Y., A. Nose, S. Kobayashi, and M. Takeichi. 1989. Expression and role of 
E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin 
morphogenesis. Development. 105:271–277.
Hu, J., S.K. Roy, P.S. Shapiro, S.R. Rodig, S.P. Reddy, L.C. Platanias, R.D. 
Schreiber,  and  D.V.  Kalvakolanu.  2001.  ERK1  and  ERK2  activate 
CCAAAT/enhancer-binding protein-beta-dependent gene transcription in 
response to interferon-gamma. J. Biol. Chem. 276:287–297. 
Kljuic, A., H. Bazzi, J.P. Sundberg, A. Martinez-Mir, R. O’Shaughnessy, M.G. 
Mahoney, M. Levy, X. Montagutelli, W. Ahmad, V.M. Aita, et al. 2003. 
Desmoglein  4  in  hair  follicle  differentiation  and  epidermal  adhesion: 
evidence from inherited hypotrichosis and acquired pemphigus vulgaris. 
Cell. 113:249–260. 
Koch, P.J., M.G. Mahoney, G. Cotsarelis, K. Rothenberger, R.M. Lavker, and 
J.R. Stanley. 1998. Desmoglein 3 anchors telogen hair in the follicle. 
J. Cell Sci. 111:2529–2537.
Kolev, V., A. Mandinova, J. Guinea-Viniegra, B. Hu, K. Lefort, C. Lambertini, V. 
Neel, R. Dummer, E.F. Wagner, and G.P. Dotto. 2008. EGFR signalling as 
a negative regulator of Notch1 gene transcription and function in prolifer-
ating keratinocytes and cancer. Nat. Cell Biol. 10:902–911. 
Lacouture, M.E. 2006. Mechanisms of cutaneous toxicities to EGFR inhibitors. 
Nat. Rev. Cancer. 6:803–812. 
Larsen, A.B., M.W. Pedersen, M.T. Stockhausen, M.V. Grandal, B. van Deurs, 
and H.S. Poulsen. 2007. Activation of the EGFR gene target EphA2   
inhibits epidermal growth factor-induced cancer cell motility. Mol. Cancer 
Res. 5:283–293. 
Lien, W.H., O. Klezovitch, and V. Vasioukhin. 2006. Cadherin-catenin proteins 
in vertebrate development. Curr. Opin. Cell Biol. 18:499–506. 
Merritt, A.J., M.Y. Berika, W. Zhai, S.E. Kirk, B. Ji, M.J. Hardman, and D.R. 
Garrod. 2002. Suprabasal desmoglein 3 expression in the epidermis of 
transgenic mice results in hyperproliferation and abnormal differentia-
tion. Mol. Cell. Biol. 22:5846–5858. 
Meyers, C., and L.A. Laimins. 1994. In vitro systems for the study and propa-
gation  of  human  papillomaviruses.  Curr.  Top.  Microbiol.  Immunol. 
186:199–215.
Miettinen, P.J., J.E. Berger, J. Meneses, Y. Phung, R.A. Pedersen, Z. Werb, and 
R. Derynck. 1995. Epithelial immaturity and multiorgan failure in mice 
lacking epidermal growth factor receptor. Nature. 376:337–341. 
Submitted: 8 September 2008
Accepted: 29 May 2009
References
Allen, E., Q.C. Yu, and E. Fuchs. 1996. Mice expressing a mutant desmosomal 
cadherin exhibit abnormalities in desmosomes, proliferation, and epider-
mal differentiation. J. Cell Biol. 133:1367–1382. 
Amagai, M., N. Matsuyoshi, Z.H. Wang, C. Andl, and J.R. Stanley. 2000. Toxin in 
bullous impetigo and staphylococcal scalded-skin syndrome targets desmo-
glein 1. Nat. Med. 6:1275–1277. 
Arnemann, J., K.H. Sullivan, A.I. Magee, I.A. King, and R.S. Buxton. 1993. 
Stratification-related expression of isoforms of the desmosomal cadherins 
in human epidermis. J. Cell Sci. 104:741–750.
Bailleul,  B.,  M.A.  Surani,  S. White,  S.C.  Barton,  K.  Brown,  M.  Blessing,  J. 
Jorcano, and A. Balmain. 1990. Skin hyperkeratosis and papilloma forma-
tion in transgenic mice expressing a ras oncogene from a suprabasal keratin 
promoter. Cell. 62:697–708. 
Bazzi, H., A. Getz, M.G. Mahoney, A. Ishida-Yamamoto, L. Langbein, J.K. Wahl 
III, and A.M. Christiano. 2006. Desmoglein 4 is expressed in highly differ-
entiated keratinocytes and trichocytes in human epidermis and hair follicle. 
Differentiation. 74:129–140. 
Brennan, D., Y. Hu, A. Kljuic, Y. Choi, S. Joubeh, M. Bashkin, J. Wahl, A. Fertala, 
L. Pulkkinen, J. Uitto, et al. 2004. Differential structural properties and 
expression patterns suggest functional significance for multiple mouse des-
moglein 1 isoforms. Differentiation. 72:434–449. 
Brennan, D., Y. Hu, S. Joubeh, Y.W. Choi, D. Whitaker-Menezes, T. O’Brien, J. 
Uitto, U. Rodeck, and M.G. Mahoney. 2007. Suprabasal Dsg2 expression 
in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant 
phenotype to keratinocytes. J. Cell Sci. 120:758–771. 
Brown, K., D. Strathdee, S. Bryson, W. Lambie, and A. Balmain. 1998. The 
malignant capacity of skin tumours induced by expression of a mutant 
H-ras transgene depends on the cell type targeted. Curr. Biol. 8:516–524. 
Brummelkamp, T.R., R. Bernards, and R. Agami. 2002. A system for stable expres-
sion of short interfering RNAs in mammalian cells. Science. 296:550–553. 
Calautti,  E.,  J.  Li,  S.  Saoncella,  J.L.  Brissette,  and  P.F.  Goetinck.  2005. 
Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differen-
tiation versus death. J. Biol. Chem. 280:32856–32865. 
Chen, J., Z. Den, and P.J. Koch. 2008. Loss of desmocollin 3 in mice leads to epi-
dermal blistering. J. Cell Sci. 121:2844–2849. 
Chen, X., S. Bonne, M. Hatzfeld, F. van Roy, and K.J. Green. 2002. Protein bind-
ing and functional characterization of plakophilin 2. Evidence for its 
diverse roles in desmosomes and beta-catenin signaling. J. Biol. Chem. 
277:10512–10522. 
Chidgey, M., C. Brakebusch, E. Gustafsson, A. Cruchley, C. Hail, S. Kirk, A. 
Merritt, A. North, C. Tselepis, J. Hewitt, et al. 2001. Mice lacking des-
mocollin 1 show epidermal fragility accompanied by barrier defects and 
abnormal differentiation. J. Cell Biol. 155:821–832. 
Chitaev, N.A., A.Z. Averbakh, R.B. Troyanovsky, and S.M. Troyanovsky. 1998. 
Molecular organization of the desmoglein-plakoglobin complex. J. Cell 
Sci. 111:1941–1949.
Cole, B.K., M. Curto, A.W. Chan, and A.I. McClatchey. 2008. Localization to the 
cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal 
growth factor receptor silencing. Mol. Cell. Biol. 28:1274–1284. 
Curto, M., B.K. Cole, D. Lallemand, C.H. Liu, and A.I. McClatchey. 2007. 
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J. Cell 
Biol. 177:893–903. 
Davies,  S.P.,  H.  Reddy,  M.  Caivano,  and  P.  Cohen.  2000.  Specificity  and 
mechanism of action of some commonly used protein kinase inhibitors. 
Biochem. J. 351:95–105. 
Den, Z., X. Cheng, M. Merched-Sauvage, and P.J. Koch. 2006. Desmocollin 3 is 
required for pre-implantation development of the mouse embryo. J. Cell 
Sci. 119:482–489. 
Denning, M.F., A.A. Dlugosz, E.K. Williams, Z. Szallasi, P.M. Blumberg, 
and S.H. Yuspa. 1995. Specific protein kinase C isozymes mediate the   
induction of keratinocyte differentiation markers by calcium. Cell Growth 
Differ. 6:149–157.
Donetti, E., M. Bedoni, E. Boschini, C. Dellavia, I. Barajon, and N. Gagliano. 
2005. Desmocollin 1 and desmoglein 1 expression in human epidermis 
and keratinizing oral mucosa: a comparative immunohistochemical and 
molecular study. Arch. Dermatol. Res. 297:31–38. 
Dusek, R.L., S. Getsios, F. Chen, J.K. Park, E.V. Amargo, V.L. Cryns, and K.J. 
Green. 2006. The differentiation-dependent desmosomal cadherin des-
moglein 1 is a novel caspase-3 target that regulates apoptosis in keratino-
cytes. J. Biol. Chem. 281:3614–3624. JCB • VOLUME 185 • NUMBER 7 • 2009   1258
Murillas, R., F. Larcher, C.J. Conti, M. Santos, A. Ullrich, and J.L. Jorcano. 
1995. Expression of a dominant negative mutant of epidermal growth fac-
tor receptor in the epidermis of transgenic mice elicits striking alterations 
in hair follicle development and skin structure. EMBO J. 14:5216–5223.
Nagasaka, T., K. Nishifuji, T. Ota, N.V. Whittock, and M. Amagai. 2004. Defining 
the pathogenic involvement of desmoglein 4 in pemphigus and staphylo-
coccal scalded skin syndrome. J. Clin. Invest. 114:1484–1492.
Perrais, M., X. Chen, M. Perez-Moreno, and B.M. Gumbiner. 2007. E-cadherin 
homophilic ligation inhibits cell growth and epidermal growth fac-
tor receptor signaling independently of other cell interactions. Mol. Biol. 
Cell. 18:2013–2025. 
Qian, X., T. Karpova, A.M. Sheppard, J. McNally, and D.R. Lowy. 2004. 
E-cadherin-mediated adhesion inhibits ligand-dependent activation of 
diverse receptor tyrosine kinases. EMBO J. 23:1739–1748. 
Reichelt, J., and T.M. Magin. 2002. Hyperproliferation, induction of c-Myc and 
14-3-3sigma, but no cell fragility in keratin-10-null mice. J. Cell Sci. 
115:2639–2650.
Reichelt, J., G. Furstenberger, and T.M. Magin. 2004. Loss of keratin 10 leads 
to  mitogen-activated  protein  kinase  (MAPK)  activation,  increased 
keratinocyte turnover, and decreased tumor formation in mice. J. Invest. 
Dermatol. 123:973–981. 
Rickman, L., D. Simrak, H.P. Stevens, D.M. Hunt, I.A. King, S.P. Bryant, R.A. 
Eady, I.M. Leigh, J. Arnemann, A.I. Magee, et al. 1999. N-terminal dele-
tion in a desmosomal cadherin causes the autosomal dominant skin dis-
ease striate palmoplantar keratoderma. Hum. Mol. Genet. 8:971–976. 
Runswick, S.K., M.J. O’Hare, L. Jones, C.H. Streuli, and D.R. Garrod. 2001. 
Desmosomal adhesion regulates epithelial morphogenesis and cell posi-
tioning. Nat. Cell Biol. 3:823–830. 
Serpente, N., C. Marcozzi, G.A. Roberts, Q. Bao, B.D. Angst, E.M. Hirst, I.D. 
Burdett, R.S. Buxton, and A.I. Magee. 2000. Extracellularly truncated 
desmoglein 1 compromises desmosomes in MDCK cells. Mol. Membr. 
Biol. 17:175–183. 
Smith, C., K. Zhu, A. Merritt, R. Picton, D. Youngs, D. Garrod, and M. Chidgey. 
2004.  Regulation  of  desmocollin  gene  expression  in  the  epidermis: 
CCAAT/enhancer-binding proteins modulate early and late events in 
keratinocyte differentiation. Biochem. J. 380:757–765. 
Stoll, S.W., S. Kansra, S. Peshick, D.W. Fry, W.R. Leopold, J.F. Wiesen, M. 
Sibilia, T. Zhang, Z. Werb, R. Derynck, et al. 2001. Differential utilization 
and localization of ErbB receptor tyrosine kinases in skin compared to 
normal and malignant keratinocytes. Neoplasia. 3:339–350. 
Teuliere, J., M.M. Faraldo, M. Shtutman, W. Birchmeier, J. Huelsken, J.P. Thiery, 
and M.A. Glukhova. 2004. beta-catenin-dependent and -independent 
effects of DeltaN-plakoglobin on epidermal growth and differentiation. 
Mol. Cell. Biol. 24:8649–8661. 
Tinkle, C.L., T. Lechler, H.A. Pasolli, and E. Fuchs. 2004. Conditional targeting 
of E-cadherin in skin: insights into hyperproliferative and degenerative 
responses. Proc. Natl. Acad. Sci. USA. 101:552–557. 
Tinkle, C.L., H.A. Pasolli, N. Stokes, and E. Fuchs. 2008. New insights into 
cadherin function in epidermal sheet formation and maintenance of tissue 
integrity. Proc. Natl. Acad. Sci. USA. 105:15405–15410. 
Traxler, P., G. Bold, E. Buchdunger, G. Caravatti, P. Furet, P. Manley, T. O’Reilly, 
J. Wood, and J. Zimmermann. 2001. Tyrosine kinase inhibitors: from 
rational design to clinical trials. Med. Res. Rev. 21:499–512. 
Wan, H., P.J. Dopping-Hepenstal, M.J. Gratian, M.G. Stone, G. Zhu, P.E. Purkis, 
A.P. South, F. Keane, D.K. Armstrong, R.S. Buxton, et al. 2004. Striate 
palmoplantar keratoderma arising from desmoplakin and desmoglein 1 
mutations is associated with contrasting perturbations of desmosomes 
and the keratin filament network. Br. J. Dermatol. 150:878–891. 
Wilanowski, T., J. Caddy, S.B. Ting, N.R. Hislop, L. Cerruti, A. Auden, L.L. 
Zhao, S. Asquith, S. Ellis, R. Sinclair, et al. 2008. Perturbed desmo-
somal cadherin expression in grainy head-like 1-null mice. EMBO J. 
27:886–897. 
Williamson, L., N.A. Raess, R. Caldelari, A. Zakher, A. de Bruin, H. Posthaus, 
R. Bolli, T. Hunziker, M.M. Suter, and E.J. Muller. 2006. Pemphigus 
vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. 
EMBO J. 25:3298–3309. 
Wu, H., Z.H. Wang, A. Yan, S. Lyle, S. Fakharzadeh, J.K. Wahl, M.J. Wheelock, 
H. Ishikawa, J. Uitto, M. Amagai, and J.R. Stanley. 2000. Protection 
against pemphigus foliaceus by desmoglein 3 in neonates. N. Engl. J. 
Med. 343:31–35. 
Yano, S., M. Komine, M. Fujimoto, H. Okochi, and K. Tamaki. 2004. Mechanical 
stretching in vitro regulates signal transduction pathways and cellular 
proliferation  in  human  epidermal  keratinocytes.  J.  Invest.  Dermatol. 
122:783–790. 